We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
-11.61%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.12B
AUM Growth
-$212M
Cap. Flow
-$32.2M
Cap. Flow %
-2.87%
Top 10 Hldgs %
21.39%
Holding
1,938
New
397
Increased
563
Reduced
612
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 16.01%
2 Healthcare 15.85%
3 Financials 12.29%
4 Consumer Discretionary 8.51%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLPH icon
1526
Talphera
TLPH
$74.7M
$3K ﹤0.01%
66
-182
-73% -$12.2K
VRDN icon
1527
Viridian Therapeutics
VRDN
$2.45B
$3K ﹤0.01%
65
+15
+30% +$867
VYGR icon
1528
Voyager Therapeutics
VYGR
$187M
$3K ﹤0.01%
271
-11
-4% -$141
WTTR icon
1529
Select Water Solutions
WTTR
$2.59B
$3K ﹤0.01%
508
-137
-21% -$1.35K
XFOR icon
1530
X4 Pharmaceuticals
XFOR
$390M
$3K ﹤0.01%
8
-33
-80% -$12.6K
PRKS icon
1531
United Parks & Resorts
PRKS
$2.07B
$3K ﹤0.01%
+151
New +$4.04K
ALTR
1532
DELISTED
Altair Engineering Inc
ALTR
$3K ﹤0.01%
+115
New +$3.79K
SYRS
1533
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3K ﹤0.01%
59
+48
+436% +$3.65K
CURO
1534
DELISTED
CURO Group Holdings Corp.
CURO
$3K ﹤0.01%
336
-378
-53% -$6.19K
PRTK
1535
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3K ﹤0.01%
603
+270
+81% +$2.05K
KDNY
1536
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$3K ﹤0.01%
225
+54
+32% +$1.08K
ALNA
1537
DELISTED
Allena Pharmaceuticals
ALNA
$3K ﹤0.01%
+541
New +$4.66K
ATHX
1538
DELISTED
Athersys, Inc. Common Stock
ATHX
$3K ﹤0.01%
+81
New +$3.87K
XELA
1539
DELISTED
Exela Technologies, Inc. Common Stock
XELA
0
APTS
1540
DELISTED
Preferred Apartment Communities, Inc.
APTS
$3K ﹤0.01%
+186
New +$2.91K
FRTA
1541
DELISTED
Forterra, Inc
FRTA
$3K ﹤0.01%
+705
New +$3.59K
ESXB
1542
DELISTED
Community Bankers Trust Corporation
ESXB
$3K ﹤0.01%
436
-725
-62% -$6.04K
USCR
1543
DELISTED
U S Concrete, Inc.
USCR
$3K ﹤0.01%
+75
New +$2.71K
FPRX
1544
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3K ﹤0.01%
+322
New +$3.83K
EIDX
1545
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$3K ﹤0.01%
245
+228
+1,341% +$2.88K
MJCO
1546
DELISTED
Majesco
MJCO
$3K ﹤0.01%
503
+311
+162% +$2.26K
NE
1547
DELISTED
Noble Corporation
NE
$3K ﹤0.01%
1,302
+826
+174% +$3.92K
DOVA
1548
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$3K ﹤0.01%
416
+345
+486% +$5.55K
BKS
1549
DELISTED
Barnes & Noble
BKS
$3K ﹤0.01%
+461
New +$3.08K
SIFI
1550
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
$3K ﹤0.01%
+200
New +$2.7K

Similar funds

Meeder Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Meeder Asset Management held 1,938 positions worth $1.12B, down 16% from $1.33B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Meeder Asset Management's Q4 2018 filing shows 397 new, 563 increased, 612 reduced and 213 closed positions. Its largest new stake was Procter & Gamble: 60,334 shares worth $5.55M. The largest sale was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $23.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • Meeder Asset Management's largest Q4 2018 buy was Procter & Gamble: 60,334 shares worth $5.55M.
  • Meeder Asset Management added most to iShares Core US Aggregate Bond ETF in Q4 2018, an estimated $29.9M increase.
  • Meeder Asset Management's biggest Q4 2018 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $23.9M.
  • Meeder Asset Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $4.28M.
  • Meeder Asset Management's ten largest holdings make up 21% of its $1.12B portfolio in Q4 2018.
  • Meeder Asset Management opened 397 new positions and closed 213 in Q4 2018.
  • Meeder Asset Management's portfolio value fell 16% quarter-over-quarter to $1.12B.

Based on Meeder Asset Management's 13F filing for Q4 2018, filed 17 Jan 2019.